No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Distribution
Galenica AG stands as a leading healthcare services company, serving both the Swiss market and international clients. Its operations are organized into two principal divisions: "Products & Care" and "Logistics & IT." The "Products & Care" division oversees an extensive network of 520 pharmacies, comprising 368 directly owned outlets and 152 partner-affiliated pharmacies, operating under the recognized brand names of Amavita, Sun Store, and Coop Vitality. Beyond retail pharmacy services, this segment also provides medication for patients receiving home-based treatment. It is also responsible for the introduction and distribution of a diverse portfolio of consumer health, pharmaceutical, and parapharmaceutical products, in addition to offering vital marketing and sales support to its collaborators within the healthcare sector. The "Logistics & IT" division specializes in offering a suite of pre-wholesale services tailored for pharmaceutical and healthcare enterprises. These services encompass essential functions such as secure storage, efficient distribution, and comprehensive debt collection. Furthermore, this segment provides various logistics and information technology solutions, including a master data system specifically developed for the healthcare industry. It actively creates advanced management solutions relevant to the healthcare market and publishes technical information on pharmaceutical products in both printed and electronic formats, alongside delivering complete management tools for pharmacies. Founded in 1927, Galenica AG maintains its headquarters in Bern, Switzerland.
www.galenica.comNo one on the platform currently holds GALE.SW.
No tracked institution reports a position in GALE.SW as of their last filing.
No one on the platform has traded GALE.SW yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 7.6% | 8.7% | 9.0% | — | — | — |
| Rev. Growth % | 5.5% | 3.5% | ||||
| Profit Margin % | 4.4% | 4.4% | 4.2% | |||
| Free Cash Flow Margin % | 6.6% | 5.3% | 5.1% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $4.4B | +6.2% | $3.75 | $3.29–$3.95 | — | 4 |
| 2027 | $4.6B | +4.0% | $4.21 | $4.19–$4.25 | — | 4 |
| 2028 | $4.7B | +3.4% | $4.49 | $4.38–$4.60 | — | 4 |
| 2029 | $4.9B | +4.2% | $4.79 | $4.67–$4.86 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 4 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-06 | $1.93 | $1.83 | -5.2% |
| 2026-03-10 | $1.99 | $1.86 | -6.5% |
| 2025-08-07 | $1.75 | $1.77 | +1.1% |
| 2025-05-22 | $1.83 | $2.09 | +14.2% |
| 2024-10-24 | $1.69 | $1.58 | -6.5% |
| 2024-03-12 | $1.66 | $1.97 | +18.7% |
| 2023-08-08 | $1.56 | $1.49 | -4.5% |
| 2023-03-07 | $1.62 |
| $1.65 |
| +1.9% |
| $492M |
| — |
| MOVE.SWMedacta Group S.A. | $111.40 | -3.47% | $2.2B | — |
| SFZN.SWSiegfried Holding AG | $73.50 | +0.48% | $3.2B | — |
Source: Financial Modeling Prep · peers by sector/industry